The association of growth factors, especially BDNF, with MDD is often indicated in the literature (Figure 3), and the likely mechanism by which SARS-CoV-2 could reduce it may prove it to be a good biomarker of post-COVID depression. The gene discussed is BDNF; the disease is depressive symptom measurement.